March 14, 2013 – FDA announces that it is investigating new studies which suggest an increased risk of pancreatitis with incretin mimetic diabetes drugs.
March 14, 2013 – FDA announces that it is investigating new studies which suggest an increased risk of pancreatitis with incretin mimetic diabetes drugs.